2013-03-28T10:11:20-05:00 2012-06-30 861065772 DELOITTE TAX LLP 100 PEABODY PLACE STE 800 MEMPHIS TN 38103 990 2011-07-01 351044585 AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC AMER 9015782000 501 ST JUDE PLACE MEMPHIS TN 381050000 JEFFREY T PEARSON 9015782000 2013-03-28 1 P00752421 9013226700 2011 2016-02-25 16:41:14Z RICHARD C SHADYAC JRCEO 501 ST JUDE PLACE MEMPHIS TN 381050000 1257177138 0 X WWW.STJUDE.ORG X 1957 IL TO BUILD AWARENESS AND RAISE FUNDS TO SUPPORT ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 47 42 1428 999999 1083436 -617645 698411243 776484977 0 0 90069200 67856711 25852788 25799003 814333231 870140691 375102514 441990544 0 0 76589183 82095094 4556510 4353600 139019210 160506301 174865211 616754508 703304449 197578723 166836242 2422814020 2506529810 41168055 52074707 2381645965 2454455103 X AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES, INC. (ALSAC) WAS FOUNDED IN 1957 AND EXISTS FOR THE SOLE PURPOSE OF BUILDING AWARENESS AND RAISING FUNDS TO SUPPORT THE CURRENT AND FUTURE OPERATING AND MAINTENACE NEEDS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 0 0 505987395 441990544 ALSAC IS THE FUNDRAISING ORGANIZATION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL. ALSAC EXISTS SOLELY TO BUILD AWARENESS AND RAISE THE FUNDS NECESSARY TO OPERATE AND MAINTAIN ST. JUDE. BECAUSE OF ALSAC, NO FAMILY EVER PAYS ST. JUDE FOR ANYTHING. IT COSTS $1.8 MILLION A DAY TO OPERATE ST. JUDE, AND MORE THAN 70 PERCENT OF ST. JUDE'S OPERATING BUDGET IS COVERED BY PUBLIC CONTRIBUTIONS GENERATED BY ALSAC FUNDRAISING PROGRAMS.ST. JUDE IS THE FIRST AND ONLY NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER DEVOTED SOLELY TO CHILDREN.WHEN ST. JUDE OPENED ITS DOORS IN 1962, IT WAS THE FIRST CHILDREN'S HOSPITAL TO BRING RESEARCH AND PATIENT CARE TOGETHER UNDER ONE ROOF.SINCE THAT TIME, ST. JUDE REVOLUTIONIZED THE WAY THE WORLD TREATS CHILDHOOD CANCER AND OTHER DISEASES LIKE SICKLE CELL. ST. JUDE DEVELOPED PROTOCOLS THAT HAVE HELPED PUSH OVERALL SURVIVAL RATES FOR CHILDHOOD CANCERS FROM LESS THAN 20 PERCENT, WHEN THE HOSPITAL OPENED IN 1962, TO 80 PERCENT TODAY.TODAY, ST. JUDE CONTINUES TO LEAD THE WAY IN FINDING CURES FOR DEADLY CHILDHOOD DISEASES THROUGH RESEARCH AND TREATMENT. ST. JUDE HAS EMBARKED ON AN UNPRECEDENTED EFFORT TO SEQUENCE THE PEDIATRIC CANCER GENOME AND TO IDENTIFY THE GENETIC CHANGES THAT GIVE RISE TO SOME OF THE WORLD'S DEADLIEST CHILDHOOD CANCERS. AND ST. JUDE CONTINUES TO UPHOLD ITS PROMISE OF CONDUCTING PIONEERING RESEARCH AND PROVIDING EXCEPTIONAL PATIENT CARE, ALL WHILE ENSURING THAT NO FAMILY EVERY PAYS ST. JUDE FOR ANYTHING. ST. JUDE COVERS THE COST OF TREATMENT ALONG WITH OTHER COSTS A FAMILY TYPICALLY INCURS WHILE THEIR CHILD IS BEING TREATED AT THE HOSPITAL. THIS INCLUDES TRAVEL, HOUSING AND FOOD. ST. JUDE ALSO MAINTAINS A SCHOOL PROGRAM TO PROVIDE OPPORTUNITIES FOR PATIENTS TO CONTINUE THEIR NORMAL EDUCATIONAL ACTIVITIES AND TO PROVIDE RE-ENTRY SERVICES TO EASE THE TRANSITION BACK TO THE COMMUNITY SCHOOL.AT ST. JUDE, WE SPEED OUR RESEARCH DISCOVERIES FROM OUR LABS TO PATIENTS AND DOCTORS EVERYWHERE SO THAT EVERY CHILD SAVED AT ST. JUDE MEANS CHILDREN SAVED AROUND THE WORLD.IN ADDITION TO CHILDHOOD CANCER, ST. JUDE PLAYS A CRITICAL LEADERSHIP ROLE IN GROUNDBREAKING STUDIES ON SICKLE CELL DISEASE, INFECTIOUS DISEASES AND GENETIC DISORDERS. THESE EFFORTS ARE INSTRUMENTAL TO IMPROVING CARE FOR CHILDREN AROUND THE WORLD. ST. JUDE WAS THE FIRST INSTITUTION TO DEVELOP A CURE FOR SICKLE CELL DISEASE WITH A BONE MARROW TRANSPLANT AND HAS ONE OF THE LARGEST PEDIATRIC SICKLE CELL PROGRAMS IN THE COUNTRY. IN ADDITION, ST. JUDE'S BRAIN TUMOR SCIENCE AND TECHNOLOGY ARE AT THE CUTTING EDGE WORLDWIDE, AND ST. JUDE HAS THE LARGEST RESEARCH-BASED PEDIATRIC BRAIN TUMOR RESEARCH PROGRAM IN THE COUNTRY. ST. JUDE IS THE COORDINATING CENTER OF THE NATIONAL PEDIATRIC BRAIN TUMOR CONSORTIUM, WHICH RECEIVES FUNDING FROM THE NATIONAL CANCER INSTITUTE.AND ST. JUDE'S EFFORTS TO SAVE THE LIVES OF CANCER PATIENTS DON'T END WHEN TREATMENT STOPS. THE ST. JUDE AFTER COMPLETION OF THERAPY (ACT) PROGRAM IS THE LARGEST LONG-TERM, FOLLOW-UP CLINIC FOR PEDIATRIC CANCER PATIENTS IN THE UNITED STATES. THE CLINIC'S ACCOMPLISHMENTS ARE NOW AN INTEGRAL PART OF NATIONAL GUIDELINES FOR SCREENING AND MANAGING THE LATE EFFECTS OF SURVIVORS OF PEDIATRIC CANCER. 505987395 1 0 0 1 0 0 0 0 0 1 1 1 0 0 1 1 1 0 0 0 1 0 0 1 1 1 0 1 0 1 0 0 0 0 0 0 1 1 1 1 0 0 0 1 0 0 0 0 1 X 993 41 1 1428 1 1 1 1 BR CH EZ EG FR GM GR HK HU IS JA MY NL NZ PE PO KS SP SW SZ TW UK 0 0 1 1 1 1 0 0 0 0 1 0 X 47 42 1 0 1 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CO CT FL GA HI IL KS KY MA MD ME MI MN MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT WA WV WI VA X X JEFFREY T PEARSON 9015782000 501 ST JUDE PLACE MEMPHIS TN 381050000 JOYCE ABOUSSIE 4.00 X 0 0 0 SUSAN MACK AGUILLARD MD 4.00 X 0 0 0 MAHIR AWDEH MD 4.00 X 0 0 0 JOSEPH S AYOUB JR ESQ 4.00 X 0 0 0 PAUL J AYOUB ESQ 4.00 X 0 0 0 JAMES B BARKATE 4.00 X 0 0 0 MARTHA PERINE BEARD 4.00 X 0 0 0 SHERYL BOURISK 4.00 X 0 0 0 ROBERT A BREIT MD 4.00 X 0 0 0 TERRY BURMAN 4.00 X 0 0 0 STEPHEN J CAMER MD 4.00 X 0 0 0 TONY CHARAF 4.00 X 0 0 0 ANN M DANNER 4.00 X 0 0 0 MICHAEL FRANCIS 4.00 X 0 0 0 FRED P GATTAS JR 4.00 X 0 0 0 FRED P GATTAS III PHARMD 4.00 X 0 0 0 CHRISTOPHER GEORGE MD 4.00 X 0 0 0 JUDY HABIB 4.00 X 0 0 0 GABRIEL GABY HADDAD MD 4.00 X 0 0 0 PAUL K HAJAR 4.00 X 0 0 0 CHUCK HAJJAR 4.00 X 0 0 0 FOUAD HAJJAR MD 4.00 X 0 0 0 FRED R HARRIS 4.00 X 0 0 0 BRUCE B HOPKINS 4.00 X 0 0 0 RICHARD IEYOUB 4.00 X 0 0 0 RICHARD KARAM ESQ 4.00 X 0 0 0 SALLI LEVAN 4.00 X 0 0 0 PAUL MARCUS 4.00 X 0 0 0 MICHAEL D MCCOY 4.00 X 0 0 0 ROBERT T MOLINET 4.00 X 0 0 0 JIM NAIFEH JR 4.00 X 0 0 0 HELEN NUGENT 4.00 X 0 0 0 RAMZI NUWAYHID 4.00 X 0 0 0 THOMAS PENN III 4.00 X 0 0 0 CAMILLE F SARROUF JR ESQ 8.00 X 0 0 0 CAMILLE F SARROUF SR ESQ 4.00 X 0 0 0 JOSEPH G SHAKER 4.00 X 0 0 0 GEORGE A SIMON II 4.00 X 0 0 0 PAUL J SIMON 4.00 X 0 0 0 TERRE THOMAS 4.00 X 0 0 0 TONY THOMAS 4.00 X 0 0 0 RICHARD M UNES 8.00 X 0 0 0 PAUL H WEIN ESQ 4.00 X 0 0 0 TOM WERTZ 4.00 X 0 0 0 RAMZI T YOUNIS MD 4.00 X 0 0 0 TAMA ZAYDON 4.00 X 0 0 0 WILLIAM E EVANS 1.00 X 0 904243 35736 RICHARD C SHADYAC JR 55.00 X X 593162 0 41732 DAVID MCKEE 55.00 X 519474 0 38974 JEFFREY PEARSON 55.00 X 272217 0 42969 EMILY CALLAHAN 55.00 X 327498 0 23072 EMILY GREER 55.00 X 254955 0 42489 SARA HALL 55.00 X 248716 0 21738 ROBERT MACHEN 55.00 X 256510 0 32197 WILLIAM REESER 55.00 X 287145 0 43903 2759677 904243 322810 105 0 1 0 INFOCISION MANAGEMENT CORPORATION 325 SPRINGSIDE DRIVE AKRON OH 443334501 CALL CENTER 2361593 MDS COMMUNICATIONS CORPORATION 545 W JUANITA AVENUE MESA AZ 852100000 CALL CENTER 1837162 RB DAVIES INC 10536 CULVER BLVD SUITE M CULVER CITY CA 902322423 MARKETING CONSULTANT 1611461 ECHO MARKETING SOLUTIONS 5075 YONGE ST SUITE 300 TORONTO, ONTARIO, CANADA ONTARIO CA CALL CENTER 921506 EURO RSCG EDGE 2173 SALK AVENUE SUITE 300 CARLSBAD CA 92008 MEDIA CONSULTANT 880118 27 8842831 1863422 765778724 4274424 776484977 25470490 25470490 48954 0 48954 48954 48954 418530603 933556 376012384 1065554 42518219 -131998 42386221 -131998 42518219 10902322 1863422 4240301 6662021 6662021 22522853 4518261 18004592 18004592 2283383 1199947 1083436 1083436 870140691 17872594 1083436 74699684 441990544 441990544 1493673 149367 1269623 74683 65126880 9381149 19769556 35976175 3972254 576877 1225636 2169741 6872534 905361 2405437 3561736 4629753 666755 1404691 2558307 1223941 186161 298819 738961 209019 209019 21899 21899 4353600 4353600 8245031 3326508 1351721 3566802 464688 48957 154231 261500 9686483 1332787 5867090 2486606 5223848 503048 1753139 2967661 5712982 981611 923381 3807990 2482881 403286 423527 1656068 7309968 851003 5091656 1367309 1392446 155902 612518 624026 MAILINGS & SHIPPING 70699140 20598424 8220932 41879784 CAMPAIGN EXPENSES 40149071 20155286 2271124 17722661 PRINTING & PUBLICATIONS 5427307 628434 800884 3997989 TELECOMMUNICATIONS 4092886 1546671 1141956 1404259 12523621 1599264 3081005 7843352 703304449 505987395 58297844 139019210 X 89077140 43091720 6609045 39376375 81663171 83405496 15244218 17361882 2132116 1981760 2211211 1306619 4676631 5755669 116893374 47702331 63213102 69191043 2253673571 2327527341 2422814020 2506529810 15964940 22998433 25203115 29076274 41168055 52074707 X 1546098870 1618940853 46913705 52799597 788633390 782714653 2381645965 2454455103 2422814020 2506529810 X 166836242 -94027104 X 0 1 1 X 0 X 627727112 658106230 659370821 698411243 776484977 3420100383 627727112 658106230 659370821 698411243 776484977 3420100383 3420100383 31062479 25255056 20199495 28793950 25519444 130830424 3428526 1129256 832925 654264 1083436 7128407 89221425 -15828592 68782839 94493447 75943394 312612513 3870671727 0.88360 0.86040 X SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: SCHEDULE A, PART II, LINE 10, EXPLANATION FOR OTHER INCOME: GAIN (LOSS) SALE OF SECURITIES GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS) GROSS GAMING RECEIPTS SCHEDULE A, PART II, LINE 10, EXPLANATION FOR OTHER INCOME: COLUMN (A): 2007 - TOTAL OF $89,221,425 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $57,640,595 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $8,743,043 C. GROSS GAMING RECEIPTS: $22,837,787 COLUMN (C): 2008 - TOTAL OF ($15,828,592) CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: ($42,101,258) B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $6,764,765 C. GROSS GAMING RECEIPTS: $19,507,901 COLUMN (D): 2009 - TOTAL OF $68,782,839 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $40,695,234 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $7,055,656 C. GROSS GAMING RECEIPTS: $21,031,949 COLUMN (E): 2010 - TOTAL OF $94,493,447 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $61,418,176 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $9,331,666 C. GROSS GAMING RECEIPTS: $23,743,605 COLUMN (F): 2011 - TOTAL OF $75,943,394 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $42,518,219 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $10,902,322 C. GROSS GAMING RECEIPTS: $22,522,853 0 0 0 0 0 0 1 21899 0 0 21899 0 EXPLANATION OF LOBBYING ACTIVITIES: PART II-B, LINE 1: LOBBYING ACTIVITIES WERE RELATED TO PROPOSED TENNESSEE LEGISLATION AMENDING CHARITABLE GIFT AGREEMENT LAWS. 0 0 788633390 3859109 -8877846 0 900000 782714653 662773900 4402533 123156706 0 1699749 788633390 590820249 4396601 69032459 0 1475409 0 662773900 723150356 10016491 -142346598 0 0 0 590820249 0.00000 1.00000 0.00000 1 0 31570808 31570808 25589216 12016530 13572686 832888 783509 49379 28069148 18939661 9129487 30831314 15962631 14868683 69191043 GLOBAL EQUITY 896280117 F MARKETABLE ALTERNATIVES 566183064 F REAL ASSETS 383035148 F PRIVATE EQUITY 175654368 F FIXED INCOME 281906661 F CASH EQUIVALENTS 24467983 F 2327527341 ANNUITY OBLIGATIONS 29076274 29076274 870140691 703304449 166836242 -94027104 -94027104 72809138 780763846 -94027104 -94027104 874790950 -4650259 -4650259 870140691 707822710 4518261 4518261 703304449 0 703304449 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: TO SUPPORT THE FUTURE NEEDS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: AS OF JUNE 30, 2012, ALSAC HAD NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS UNDER ASC TOPIC 740, INCOME TAXES, REQUIRING ADJUSTMENTS TO ITS FINANCIAL STATEMENTS. IN THE EVENT ALSAC WERE TO RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IT WOULD BE RECOGNIZED IN THE FINANCIAL STATEMENTS AS A GENERAL EXPENSE. GENERALLY, TAX YEARS ENDING IN 2009 THROUGH 2012 ARE OPEN TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES, RESPECTIVELY. THERE ARE NO INCOME TAX EXAMINATIONS CURRENTLY IN PROCESS. PART XII, LINE 4B - OTHER ADJUSTMENTS: NET LOSS FROM DISPOSAL OF PROPERTY AND EQUIPMENT -131,998. DIRECT GAMING EXPENSES -4,518,261. PART XIII, LINE 2D - OTHER ADJUSTMENTS: DIRECT GAMING EXPENSES 4,518,261. EAST ASIA AND THE PACIFIC 0 0 INVESTMENTS 4357181 EUROPE 0 0 INVESTMENTS 16237525 SOUTH AMERICA 0 0 INVESTMENTS 1360277 0 0 0 0 0 0 21954983 0 21954983 1 0 0 1 1 0 X X X X X X 1 INFOCISION MANAGEMENT CORP 325 SPRINGSIDE DRIVE AKRON OH 443334501 CALL CENTER 0 2334194 1998186 336008 MDS COMMUNICATIONS CORP 545 W JUANITA AVE MESA AZ 852100000 CALL CENTER 0 1701444 1499140 202304 ECHO MARKETING SOLUTIONS INC SUITE 300 TORONTO ONTARIO CA CALL CENTER 0 1202655 856274 346381 5238293 4353600 884693 AK AL AR AZ CA CO CT FL GA HI IL KS KY ME MD MA MI MN MS NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI GALA 1559182 349072 1210110 0 24780 0 123672 19609 23969 GALA 712087 63364 648723 0 8473 0 1814 8098 45155 118 10494475 1450986 9043489 0 112583 564449 1389130 715262 1203307 12765744 1863422 10902322 145836 564449 1514616 742969 1272431 4240301 6662021 22522853 0 4504920 13341 0 1 0.10000 22522853 4504920 13341 4518261 18004592 CA GA IL IN KY LA MS MO OH TX TN VA WV NY RI MA MN DC CO MI 1 0 1 0 0.05000 0.95000 JEFFREY PEARSON 501 ST JUDE PLACE MEMPHIS TN 381050000 0 BRIAN DOYLE 104558 MANAGES THE PLANNING AND EXECUTION OF RAFFLE ACTIVITIES X 0 EXPLANATION OF FUNDRAISING PAYMENTS SCHEDULE G, PART I, LINE 2B, COLUMN (V) FUNDRAISING SERVICES ARE FOR SERVICES ONLY AND ARE PAID AS A FIXED FEE. USE OF PROFESSIONAL FUNDRAISERS IS RELATED MOSTLY TO DONOR CULTIVATION, AND WHILE THERE IS AN UPFRONT INVESTMENT, THE LIFETIME VALUE IN GIVING OF THESE DONORS GENERATES SIGNIFICANT VALUE TO ST. JUDE IN THE LONG-TERM. NO CONTRACTS WITH PROFESSIONAL FUNDRAISERS CONTAIN PROVISIONS FOR REIMBURSEMENT OF FUNDRAISING EXPENSES. 1 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 501(C)(3) 441990544 0 OPERATE HOSPITAL 1 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: THE SOLE RECIPIENT OF GRANTS AND SUPPORT IS ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. ALSAC IS THE FUNDRAISING ORGANIZATION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL. ALSAC EXISTS SOLELY TO BUILD AWARENESS AND RAISE THE FUNDS NECESSARY TO OPERATE AND MAINTAIN ST. JUDE. IT COSTS $1.8 MILLION A DAY TO OPERATE ST. JUDE, AND MORE THAN 70 PERCENT OF ST. JUDE'S OPERATING BUDGET IS COVERED BY PUBLIC CONTRIBUTIONS GENERATED BY ALSAC FUNDRAISING PROGRAMS. X X X 1 1 X X X X X 0 0 0 0 0 0 0 0 0 WILLIAM E EVANS 0 782166 0 0 0 122077 0 26950 0 8786 0 939979 0 0 RICHARD C SHADYAC JR 591920 0 0 0 1242 0 25027 0 16705 0 634894 0 0 0 DAVID MCKEE 505416 0 0 0 14058 0 25027 0 13947 0 558448 0 0 0 JEFFREY PEARSON 271568 0 0 0 649 0 25027 0 17942 0 315186 0 0 0 EMILY CALLAHAN 327108 0 0 0 390 0 5853 0 17219 0 350570 0 0 0 EMILY GREER 254355 0 0 0 600 0 25027 0 17462 0 297444 0 0 0 SARA HALL 248322 0 0 0 394 0 2858 0 18880 0 270454 0 0 0 ROBERT MACHEN 256110 0 0 0 400 0 15817 0 16380 0 288707 0 0 0 WILLIAM REESER 285171 0 0 0 1974 0 25027 0 18876 0 331048 0 0 0 PART I, LINE 1A TRAVEL FOR COMPANIONS: PAYMENT FOR COMPANION TRIPS IS AN INFREQUENT PRACTICE. IT IS LIMITED TO INSTANCES WHERE IT IS NECESSARY, APPROPRIATE AND EXPECTED FOR THE CEO'S SPOUSE TO PARTICIPATE IN HOSTING AND REPRESENTING ALSAC. TAX INDEMNIFICATION AND GROSS-UP PAYMENTS: PAYMENTS MADE TO ELIGIBLE EMPLOYEES FOR CERTAIN TAXABLE RETIREMENT BENEFITS WERE GROSSED-UP FOR TAX INDEMNIFICATION PURPOSES. HEALTH OR SOCIAL CLUB DUES: A SOCIAL CLUB MEMBERSHIP WAS MADE AVAILABLE TO THE CEO BUT LIMITED TO BUSINESS PURPOSES IN ACCORDANCE WITH A WRITTEN POLICY DIRECTIVE. PART II: WILLIAM E. EVANS SERVES AS A VOTING DIRECTOR OF THE BOARD OF ALSAC. DR. EVANS IS EMPLOYED AS AN OFFICER OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, AN ORGANIZATION RELATED TO ALSAC. THE COMPENSATION SHOWN IN COLUMNS (B), (D), AND (E) WAS PAID TO DR. EVANS BY ST. JUDE FOR HIS DUTIES AS CEO OF ST. JUDE. MIKE FOWLER FAMILY MEMBER OF DAVID MCKEE, OFFICER 94962 EMPLOYMENT 0 KHJ ENTITY MORE THAN 35% OWNED BY JUDY HABIB, DIRECTOR 145984 CONSULTING 0 X 7 X 4 X 1 X 355 4274424 COST OR SELLING PRICE X PRIZE PACKAGES 124 X GIFT CARDS 26 X MISCELLANEOUS 264 1 0 1 0 NON REPORTING OF REVENUE: PART I, LINE 33: PART I, COLUMN (C), LINE 1 - ART - WORKS OF ART- REVENUES ARE INCLUDED IN FORM 990, PART VIII, LINES 8A (FUNDRAISING EVENTS) AND 9A (GAMING). LINE 6 - CARS AND OTHER VEHICLES- REVENUES ARE INCLUDED IN FORM 990, PART VIII, LINES 8A (FUNDRAISING EVENTS) AND 9A (GAMING). LINE 7 - BOATS AND PLANES- REVENUES ARE INCLUDED IN FORM 990, PART VIII, LINES 8A (FUNDRAISING EVENTS) AND 9A (GAMING). LINE 25 - PRIZE PACKAGE- REVENUES ARE INCLUDED IN FORM 990, PART VIII, LINES 8A (FUNDRAISING EVENTS) AND 9A (GAMING). LINE 26 - GIFT CARDS - REVENUES ARE INCLUDED IN FORM 990, PART VIII, LINES 8A (FUNDRAISING EVENTS) AND 9A (GAMING). LINE 27 - MISCELLANEOUS- REVENUES ARE INCLUDED IN FORM 990, PART VIII, LINES 8A (FUNDRAISING EVENTS) AND 9A (GAMING). FORM 990, PART VI, SECTION A, LINE 2 FAMILY RELATIONSHIPS AMONG DIRECTORS: JOSEPH S. AYOUB, JR., PAUL J. AYOUB, ROBERT A. BREIT, MD, FRED P. GATTAS, JR., FRED P. GATTAS, III, CAMILLE F. SARROUF, SR., CAMILLE F. SARROUF, JR., JOSEPH G. SHAKER, GEORGE A. SIMON II, PAUL J. SIMON, TONY THOMAS, TERRE THOMAS. BUSINESS RELATIONSHIPS AMONG DIRECTORS: ROBERT A. BREIT, MD AND JOSEPH G. SHAKER. FORM 990, PART VI, SECTION A, LINE 4 THE ALSAC BYLAWS WERE REVIEWED AND REVISED BY THE LEGAL AND COMPLIANCE COMMITTEE AND APPROVED BY THE BOARD. THERE WERE TECHNICAL AND CLARIFICATION EDITS TO EVERY ARTICLE OF THE BYLAWS AND THE FOLLOWING REPRESENTS A SUMMARY OF THE SIGNIFICANT EDITS: ARTICLE 4 BOARD, SECTION 6 POWERS AND DUTIES OF THE BOARD - THE BYLAW PROVISION RELATIVE TO APPROVAL OF EXPENDITURES BY THE BOARD WAS AMENDED TO PROVIDE THAT IF MANAGEMENT ANTICIPATES THAT EXPENDITURES OF THE OPERATING OR CAPITAL BUDGETS WILL EXCEED THE BOARD APPROVED FISCAL YEAR BUDGET BY MORE THAN ONE MILLION DOLLARS ($1,000,000), THE CEO SHALL NOTIFY THE BOARD CHAIRPERSON AND RECEIVE PRIOR BOARD APPROVAL. ARTICLE 4 BOARD, SECTION 9 ATTENDANCE - THE BYLAWS WERE AMENDED TO REPLACE THE "REQUIREMENT" WITH THE "EXPECTATION" THAT EACH MEMBER BE PHYSICALLY PRESENT FOR AT LEAST THREE (3) MEETINGS OF THE BOARD AND ALL COMMITTEE MEETINGS FOR WHICH HE OR SHE IS A MEMBER, EXCEPT WHERE GOOD CAUSE IS SHOWN. THE BYLAWS WERE CLARIFIED TO ALLOW MEMBERS TO PARTICIPATE BY TELEPHONE OR OTHER ELECTRONIC COMMUNICATIONS. ARTICLE 4 BOARD, SECTION 10 ACTION BY CONSENT OF BOARD - THIS PROVISION WAS AMENDED TO PROVIDE THAT BOARD ACTION MAY BE TAKEN WITHOUT A MEETING IF ALL VOTING MEMBERS CONSENT IN WRITING AND CERTAIN OTHER PROCEDURAL AND NOTICE REQUIREMENTS ARE MET. ARTICLE 4 BOARD, SECTION 11 QUORUM - THE BOARD QUORUM REQUIREMENT WAS INCREASED FROM ONE THIRD (1/3) TO ONE HALF (1/2) THE NUMBER OF VOTING, ELECTED MEMBERS OF THE BOARD. ARTICLE 4 THE BOARD, SECTION 13 COMPENSATION - THIS SECTION WAS CLARIFIED TO PROVIDE THAT NO BOARD MEMBER SHALL RECEIVE COMPENSATION FOR BOARD SERVICE AND THAT ALL RELATIONSHIPS BETWEEN BOARD MEMBERS AND ALSAC SHALL BE SUBJECT TO THE CONFLICTS OF INTEREST POLICY. ARTICLE 5 BOARD OFFICERS, SECTION 6 CEO - THE CEO DUTIES WERE CLARIFIED TO PROVIDE THAT THE CEO IS RESPONSIBLE FOR THE AFFAIRS AND FUNDRAISING ACTIVITIES OF ALSAC AND THAT THE CEO IS AN EX OFFICIO, VOTING MEMBER OF THE BOARD AND A NON-VOTING, EX OFFICIO MEMBER OF ALL STANDING COMMITTEES EXCEPT AUDIT, COMPENSATION, CONFLICTS OF INTEREST, LIAISON OR NOMINATING. ARTICLE 6 STANDING AND AD HOC COMMITTEES, SECTION 1 STANDING COMMITTEES - THE NAME OF THE LEGAL & BYLAWS COMMITTEE WAS CHANGED TO THE LEGAL AND COMPLIANCE COMMITTEE, AND THAT THE CONFLICT OF INTEREST AND GOVERNANCE COMMITTEES WERE ADDED TO THE LIST OF STANDING COMMITTEES. ARTICLE 7 EXECUTIVE MANAGEMENT BOARD - THIS SECTION RELATED TO A SUBSET OF THE BOARD, WHICH HAD AUTHORITY TO ACT IN CERTAIN INSTANCES WITHOUT THE APPROVAL OF THE ENTIRE BOARD, AND WAS DELETED IN ITS ENTIRETY. ARTICLE 9 REAL ESTATE - THIS SECTION WAS AMENDED TO GIVE THE CEO AUTHORITY TO PURCHASE UP TO $1,000,000 IN REAL ESTATE AND TO SELL REAL ESTATE NOT BEING ACTIVELY USED FOR OPERATIONS FOR UP TO $3,000,000. ARTICLE 11 AMENDMENTS, SECTION 1 VOTE REQUIRED - THIS SECTION WAS AMENDED TO REQUIRE A VOTE OF 75% OF THE VOTING MEMBERS OF THE BOARD TO AMEND CERTAIN BOARD ELIGIBILITY PROVISIONS AND THE BYLAWS PROVISION RELATED TO THIS REQUIREMENT. ARTICLE 12 LIMITED LIABILITY OF MEMBERS AND OFFICERS AND ARTICLES 13 INDEMNIFICATION - THESE SECTIONS WERE UPDATED AS APPROPRIATE DUE TO STATUTORY AND OTHER CHANGES. FORM 990, PART VI, SECTION B, LINE 11 IN FEBRUARY OF EACH YEAR, THE AUDIT COMMITTEE AND OFFICERS OF THE BOARD ARE PROVIDED WITH A DRAFT COPY OF FORM 990 AND ALL REQUIRED SCHEDULES. THE AUDIT COMMITTEE MEETS WITH ITS TAX PREPARER TO REVIEW THE DRAFT FORM 990 BEFORE IT IS FILED WITH IRS. ADDITIONALLY, THE COMPENSATION COMMITTEE OF THE BOARD RECEIVES A DRAFT COPY OF THE COMPENSATION SECTIONS OF FORM 990 FOR REVIEW BEFORE IT IS FILED WITH IRS. EACH VOTING MEMBER OF THE BOARD RECEIVES A FINAL COPY OF FORM 990 WITH ALL REQUIRED SCHEDULES BEFORE IT IS FILED WITH IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION MAINTAINS AN AD HOC CONFLICT OF INTEREST COMMITTEE OF THE BOARD OF DIRECTORS. IN ADDITION TO EXTENSIVE EDUCATION OF NEW BOARD MEMBERS ON THE CONFLICT OF INTEREST POLICY, THE EXECUTIVE ADMINISTRATOR TO THE BOARD ACTIVELY MONITORS CONFLICT MANAGEMENT PLANS (WHICH MAY INCLUDE CHANGING VENDORS, DIVESTITURE OF FINANCIAL INTERESTS, AND THE LIKE) TO ENSURE THEY ARE COMPLETED IN A TIMELY FASHION. UNDISCLOSED CONFLICTS ARE DISCOVERED, WHERE POSSIBLE, THROUGH THE ORGANIZATION'S CONTRACTING PROCESS. THIS IS TRUE FOR THE BOARD'S CONFLICT OF INTEREST POLICY AND FOR THE SEPARATE CONFLICT OF INTEREST POLICY APPLICABLE TO ALL FACULTY AND ADMINISTRATION OF THE ORGANIZATION (POTENTIAL CONFLICTS OF THE ORGANZATION ARE DISCUSSED AND RESOLVED AT A SENIOR-LEVEL CONFLICTS OF INTEREST COMMITTEE). POTENTIAL RESTRICTIONS RANGE FROM UNWINDING OR PROHIBITING A TRANSACTION, TO PREVENTING SOMEONE FROM PARTICIPATING IN A DELIBERATION, TO SIMPLE DISCLOSURE TO THE BOARD OF THE CONFLICTING INTEREST, DEPENDING ON THE FACTS AND CIRCUMSTANCES OF THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD COMMISSIONS REGULAR SALARY SURVEYS FOR THE CEO, COO, CFO, CHIEF MARKETING OFFICER, CHIEF DEVELOPMENT OFFICER, CHIEF LEGAL OFFICER, AND CHIEF INVESTMENT OFFICER. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED LOSSES ON INVESTMENTS: -94,027,104. WILLIAM E. EVANS SCHEDULE J, PART II WILLIAM E. EVANS SERVES AS A VOTING DIRECTOR OF THE BOARD OF ALSAC. DR. EVANS IS EMPLOYED AS AN OFFICER OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, AN ORGANIZATION RELATED TO ALSAC. THE COMPENSATION SHOWN IN COLUMN (E) WAS PAID BY ST. JUDE FOR HIS DUTIES AS CEO OF ST. JUDE. FOREIGN COUNTRIES FORM 990, PART V, LINE 4B THE FINANCIAL ACCOUNTS IN THE FOREIGN COUNTRIES LISTED ON FORM 990, PART V, LINE 4B (AND SCHEDULE O) ARE RELATED TO INVESTMENTS. NO FINANCIAL ACCOUNTS FOR OPERATIONAL PURPOSES WERE MAINTAINED IN FOREIGN COUNTRIES. ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS BLVD MEMPHIS TN 381050000 620646012 HOSPITAL TN SECTION 501(C)(3) SEC 170(B) (1)(A)(II 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC B 441990544 CASH VALUE ST JUDE CHILDREN'S RESEARCH HOSPITAL INC K 441990544 CASH VALUE ST JUDE CHILDREN'S RESEARCH HOSPITAL INC O 830803 CASH VALUE ST JUDE CHILDREN'S RESEARCH HOSPITAL INC P 898773 CASH VALUE SCHEDULE R, PART V ALL TRANSACTIONS BETWEEN THE RELATED ORGANIZATIONS WERE CASH PAYMENTS.